Artia Global Partners LP Verona Pharma PLC Transaction History
Artia Global Partners LP
- $367 Billion
- Q3 2024
A detailed history of Artia Global Partners LP transactions in Verona Pharma PLC stock. As of the latest transaction made, Artia Global Partners LP holds 148,590 shares of VRNA stock, worth $8.55 Million. This represents 1.17% of its overall portfolio holdings.
Number of Shares
148,590
Previous 130,790
13.61%
Holding current value
$8.55 Million
Previous $1.89 Billion
126.04%
% of portfolio
1.17%
Previous 0.37%
Shares
4 transactions
Others Institutions Holding VRNA
# of Institutions
172Shares Held
68.6MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$363 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$321 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$288 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$243 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$204 Million14.95% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.51B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...